Search Filters
Tags
osteoarthritis
Clear All
Search
Tags
osteoarthritis
61 results found in 52ms
Knee cartilage damage left untreated and when repair helps
avatar
Miss Sophie Harris
12/8/2026
Knee cartilage damage left untreated and when repair helps
Cartilage lacks blood vessels, nerve fibres, and lymph channels, so repair cells cannot reach injuries and pain does not warn of damage, allowing lesions to expand silently until they become clinically serious.Cartilage lacks blood vessels, nerve fibres, and lymph channels, so repair cells cannot reach injuries and pain does not warn of damage, allowing lesions to expand silently until they become clinically serious.
ChondroFiller versus hyaluronic acid for cartilage defects
avatar
Miss Sophie Harris
3/8/2026
ChondroFiller versus hyaluronic acid for cartilage defects
ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.
Who qualifies for ChondroFiller Liquid Cartilage injection
avatar
Miss Sophie Harris
26/7/2026
Who qualifies for ChondroFiller Liquid Cartilage injection
ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
What ChondroFiller's CE approval means for UK patients
avatar
Miss Sophie Harris
20/7/2026
What ChondroFiller's CE approval means for UK patients
ChondroFiller recruits the body's progenitor cells to repair focal cartilage defects, achieving symptom relief in 70–85% of selected patients, though it offers no benefit for widespread osteoarthritis.ChondroFiller recruits the body's progenitor cells to repair focal cartilage defects, achieving symptom relief in 70–85% of selected patients, though it offers no benefit for widespread osteoarthritis.
Who qualifies for a ChondroFiller injection
avatar
Miss Sophie Harris
13/7/2026
Who qualifies for a ChondroFiller injection
ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.
When hip pain needs a specialist
avatar
Miss Sophie Harris
11/7/2026
When hip pain needs a specialist
Hip pain persisting beyond two weeks, disrupting sleep or preventing stairs and dressing, warrants GP assessment; specialist referral typically requires prior documentation of 8–12 weeks of conservative management.Hip pain persisting beyond two weeks, disrupting sleep or preventing stairs and dressing, warrants GP assessment; specialist referral typically requires prior documentation of 8–12 weeks of conservative management.
How long ChondroFiller results last
avatar
Miss Sophie Harris
4/7/2026
How long ChondroFiller results last
ChondroFiller's collagen scaffold biodegrades within 6–24 months, yet provides lasting clinical benefit by recruiting the patient's own cells to form repair tissue; 70–85% of well-selected patients maintain meaningful symptom relief at three to five years.ChondroFiller's collagen scaffold biodegrades within 6–24 months, yet provides lasting clinical benefit by recruiting the patient's own cells to form repair tissue; 70–85% of well-selected patients maintain meaningful symptom relief at three to five years.
Telling a meniscus tear from knee arthritis
avatar
Miss Sophie Harris
29/6/2026
Telling a meniscus tear from knee arthritis
A meniscus tear begins at an identifiable moment. Osteoarthritis doesn't—it accumulates silently over months or years. This difference in onset is the single most reliable way to tell them apart.A meniscus tear begins at an identifiable moment. Osteoarthritis doesn't—it accumulates silently over months or years. This difference in onset is the single most reliable way to tell them apart.
Who qualifies for ChondroFiller injection
avatar
Miss Sophie Harris
26/6/2026
Who qualifies for ChondroFiller injection
ChondroFiller targets Grade III and IV cartilage damage—focal defects or distributed osteoarthritis—using a collagen scaffold to support biological repair across both presentations, provided joint mechanical stability remains intact.ChondroFiller targets Grade III and IV cartilage damage—focal defects or distributed osteoarthritis—using a collagen scaffold to support biological repair across both presentations, provided joint mechanical stability remains intact.
When is it too late for cartilage repair?
avatar
Miss Sophie Harris
9/6/2026
When is it too late for cartilage repair?
Once cartilage loss becomes generalised and surfaces contact bone, no restoration procedure works; repair is viable only for focal defects.Once cartilage loss becomes generalised and surfaces contact bone, no restoration procedure works; repair is viable only for focal defects.
ChondroFiller durability vs Arthrosamid and hyaluronic acid
avatar
Miss Sophie Harris
6/6/2026
ChondroFiller durability vs Arthrosamid and hyaluronic acid
ChondroFiller's collagen scaffold breaks down in six to twenty-four months, but the clinical benefit lasts one to five years or longer because the material recruits the patient's own progenitor cells to support cartilage repair, not to act as permanent filling.ChondroFiller's collagen scaffold breaks down in six to twenty-four months, but the clinical benefit lasts one to five years or longer because the material recruits the patient's own progenitor cells to support cartilage repair, not to act as permanent filling.
ChondroFiller success rates in practice
avatar
Miss Sophie Harris
5/6/2026
ChondroFiller success rates in practice
ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.
61 results found in 52ms